M. G. M. Smith

1.3k total citations
20 papers, 1.0k citations indexed

About

M. G. M. Smith is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, M. G. M. Smith has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 11 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in M. G. M. Smith's work include Liver Diseases and Immunity (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Macrophage Migration Inhibitory Factor (5 papers). M. G. M. Smith is often cited by papers focused on Liver Diseases and Immunity (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Macrophage Migration Inhibitory Factor (5 papers). M. G. M. Smith collaborates with scholars based in United Kingdom, United States and Italy. M. G. M. Smith's co-authors include Roger Williams, A L Eddleston, Deborah Doniach, C. G. Mitchell, Robert M. Galbraith, W D Reed, P. L. Golding, D. E. H. Tee, Mario Rizzetto and G. Walker and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

M. G. M. Smith

20 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. G. M. Smith United Kingdom 14 600 544 168 157 102 20 1.0k
I G McFarlane United Kingdom 22 937 1.6× 793 1.5× 139 0.8× 180 1.1× 239 2.3× 43 1.4k
Nancy Bach United States 17 1.3k 2.2× 1.2k 2.2× 91 0.5× 402 2.6× 180 1.8× 33 1.6k
R Chapman United Kingdom 17 586 1.0× 432 0.8× 62 0.4× 549 3.5× 143 1.4× 30 1.1k
Naohide Tanaka Japan 18 785 1.3× 669 1.2× 67 0.4× 135 0.9× 82 0.8× 73 1.2k
Jorge Findor Argentina 12 410 0.7× 361 0.7× 37 0.2× 104 0.7× 119 1.2× 33 652
W Wepler Germany 6 578 1.0× 625 1.1× 35 0.2× 45 0.3× 58 0.6× 16 807
Jacques Denis France 16 641 1.1× 556 1.0× 59 0.4× 291 1.9× 23 0.2× 61 1.0k
István Tornai Hungary 18 546 0.9× 529 1.0× 87 0.5× 240 1.5× 46 0.5× 90 1.0k
G. Bellati Italy 23 1.2k 2.0× 1.0k 1.9× 50 0.3× 271 1.7× 96 0.9× 49 1.4k
Paolo Montalto Italy 9 676 1.1× 495 0.9× 73 0.4× 311 2.0× 93 0.9× 17 887

Countries citing papers authored by M. G. M. Smith

Since Specialization
Citations

This map shows the geographic impact of M. G. M. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. G. M. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. G. M. Smith more than expected).

Fields of papers citing papers by M. G. M. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. G. M. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. G. M. Smith. The network helps show where M. G. M. Smith may publish in the future.

Co-authorship network of co-authors of M. G. M. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of M. G. M. Smith. A scholar is included among the top collaborators of M. G. M. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. G. M. Smith. M. G. M. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, Jay S., et al.. (2004). Inhibition of Progenitor Cell Proliferation in the Dentate Gyrus of Rats Following Post-Weaning Lead Exposure. NeuroToxicology. 26(1). 141–145. 21 indexed citations
2.
Smith, M. G. M.. (2002). Does infliximab improve liver function tests in patiens with primary sclerosing cholangitis?. The American Journal of Gastroenterology. 97(9). S71–S71. 2 indexed citations
3.
Gama, Rousseau, et al.. (1997). Hyperthyroidism from an Embryonal Carcinoma. Journal of the Royal Society of Medicine. 90(8). 446–447. 2 indexed citations
4.
Ingerman-Wojenski, C.M., M. G. M. Smith, & Melvin J. Silver. (1987). Alloxan-induced hyperglycemia in rabbits and the response of platelets to aggregating agents in vitro and to exposed subendothelium in vivo. Thrombosis Research. 46(5). 635–647. 3 indexed citations
5.
Smith, M. G. M., et al.. (1981). Serum “prealbumin” as an index of liver function in human hepatobiliary disease. Clinica Chimica Acta. 114(1). 69–74. 28 indexed citations
6.
Crowe, John, Erik Christensen, M. G. M. Smith, et al.. (1980). Azathioprine in primary biliary cirrhosis: A preliminary report of an international trial. Gastroenterology. 78(5). 1005–1010. 68 indexed citations
7.
Smith, M. G. M., A L Eddleston, & Roger Williams. (1975). Immunological Factors in the Evolution of Active Chronic Hepatitis and other Autoimmune Liver Diseases. Clinics in Gastroenterology. 4(2). 297–313. 9 indexed citations
8.
Galbraith, Robert M., A L Eddleston, M. G. M. Smith, et al.. (1974). Histocompatibility Antigens in Active Chronic Hepatitis and Primary Biliary Cirrhosis. BMJ. 3(5931). 604–605. 84 indexed citations
9.
Smith, M. G. M., Roger Williams, G. Walker, Mario Rizzetto, & Deborah Doniach. (1974). Hepatic Disorders Associated with Liver/Kidney Microsomal Antibodies. BMJ. 2(5910). 80–84. 84 indexed citations
10.
Galbraith, Robert M., et al.. (1974). High Prevalence of Seroimmunologic Abnormalities in Relatives of Patients with Active Chronic Hepatitis or Primary Biliary Cirrhosis. New England Journal of Medicine. 290(2). 63–69. 116 indexed citations
11.
Smith, M. G. M., et al.. (1973). Studies on the Incidence and Pathogenesis. 9 indexed citations
12.
Smith, M. G. M., et al.. (1973). Multisystem involvement in chronic liver disease. The American Journal of Medicine. 55(6). 772–782. 174 indexed citations
13.
Williams, Roger, M. G. M. Smith, Κ.B. Shilkin, et al.. (1973). Liver Transplantation in Man: The Frequency of Rejection, Biliary Tract Complications, and Recurrence of Malignancy Based on an Analysis of 26 Cases. Gastroenterology. 64(5). 1026–1048. 61 indexed citations
14.
Smith, M. G. M., et al.. (1972). Cell-mediated Immune Responses in Chronic Liver Diseases. BMJ. 1(5799). 527–530. 78 indexed citations
15.
Mitchell, C. G., et al.. (1972). CELL-MEDIATED IMMUNITY TO A HUMAN LIVER-SPECIFIC ANTIGEN IN PATIENTS WITH ACTIVE CHRONIC HEPATITIS AND PRIMARY BILIARY CIRRHOSIS. The Lancet. 300(7772). 296–297. 139 indexed citations
16.
Smith, M. G. M., et al.. (1972). TOTAL HAEMOLYTIC COMPLEMENT AFTER LIVER TRANSPLANTATION AND IN LIVER DISEASE. Transplantation. 14(1). 41–46. 6 indexed citations
17.
Smith, M. G. M., et al.. (1972). Evaluation of the leucocyte migration test as a measure of delayed hypersensitivty in man. Suppression of migration inhibition by puromycin.. PubMed. 11(4). 535–41. 44 indexed citations
18.
Eddleston, A.L.W.F., et al.. (1971). APPLICATION OF THE LEUCOCYTE MIGRATION TEST TO THE DIAGNOSIS OF REJECTION AFTER LIVER TRANSPLANTATION. Transplantation. 12(1). 11–17. 16 indexed citations
19.
Mitchell, C. G., M. G. M. Smith, A L Eddleston, & Roger Williams. (1970). SERUM IMMUNOSUPPRESSIVE ACTIVITY DUE TO AZATHIOPRINE AND ITS RELATION TO HEPATIC FUNCTION AFTER LIVER TRANSPLANTATION. The Lancet. 295(7658). 1196–1199. 24 indexed citations
20.
Smith, M. G. M., A L Eddleston, Jessica A. Dominguez, et al.. (1969). Changes in leucocyte migration after renal transplantation. BMJ. 4(5678). 275–278. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I G McFarlane Breakdown of academic impact, for papers by Nancy Bach Breakdown of academic impact, for papers by R Chapman Breakdown of academic impact, for papers by Naohide Tanaka Breakdown of academic impact, for papers by Jorge Findor Breakdown of academic impact, for papers by W Wepler Breakdown of academic impact, for papers by Jacques Denis Breakdown of academic impact, for papers by István Tornai Breakdown of academic impact, for papers by G. Bellati Breakdown of academic impact, for papers by Paolo Montalto
Rankless by CCL
2026